Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHYR.L Regulatory News (HYR)

  • There is currently no data for HYR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

20 Jul 2016 07:00

RNS Number : 6713E
HydroDec Group plc
20 July 2016

20 July 2016

Hydrodec Group plc

("Hydrodec", the "Company" or the "Group")

Trading Update

Hydrodec Group plc (AIM: HYR), the cleantech industrial oil re-refining group is pleased to provide a trading update in respect of the six month period ended 30 June 2016.

Highlights

Increased Group sales volumes of premium quality SUPERFINE transformer oil and base oil in H1 of 16.75 million litres (H1 2015: 1.7 million litres), reflecting full commissioning of new Canton plant at the end of 2015 - record monthly sales in June of 3.2m litres

Improving plant utilisation - Canton reaching 76% in May

Continued successful production in Australia and improving feedstock position

Revenues from continuing core re-refining business for H1 2016 expected to increase by approximately 130% to US$7.6 million (H1 2015: US$3.3 million)

H1 2016 gross unit margins in continuing business higher than H1 2015 despite lower product sales prices and challenging market conditions

Disposal of loss-making UK recycling operations in March

Update

The Board is pleased to report significant progress in delivering the Company's key objectives since the beginning of the year.

The main drivers in 2016 have been to refocus on the core transformer oil re-refining technology by optimising the performance of the Canton facility, and to increase production levels through a combination of leveraging the experience gained since fully commissioning the plant at the end of last year along with specific targeted operating improvements. These improvements have been validated by the significantly lower number of production hours lost through unscheduled stoppages and the record monthly production performance of the plant in May of 2.82 million litres of SUPERFINE transformer oil and base oil.

An additional primary objective relates to improving the sales mix between higher margin transformer oil and lower margin base oil produced at the Canton plant. At the beginning of the year, January transformer oil sales represented 19% of US volumes sold. Since then significant improvements have been made in this area and in June transformer oil represented 71% of sales, with further advances expected.

In respect of the operations in Australia, since the commissioning of the plant at the Southern Oil Refinery in May 2015 we have had to work extremely hard to re-establish our commercial position in the market. I am pleased to report that in May, the Australian business enjoyed one of its highest feedstock acquisition months since 2012 and the underlying pipeline continues to grow steadily.

Finally, there has been a key focus on the reduction of corporate costs. Significant reductions have already been realised with the expectation that the benefits from more recently implemented initiatives will filter through in H2.

Given that the Group's key operations are in the US and Australia, the Board does not expect there to be any material impact on the Group's performance as a result of the Brexit referendum.

Outlook

In summary, the information provided today confirms significant progress in the turnaround of the Company over the first half of the year. Our key objective during the rest of the year is to strengthen margins as we grow market share whilst continuing the program of cost reduction. We continue to make strong progress towards positive Group EBITDA in the second half of the year.

Chris Ellis, Chief Executive Officer of Hydrodec, commented: "I am pleased to be able to report significant progress in moving Hydrodec towards profitability and expanding its position in the transformer oil market in our key operating arenas. Whilst market conditions remain challenging, we are focused on delivering our operational plans and also primed to take advantage of the opportunities the current market may yet present to grow the business both in our existing areas of focus and in new markets."

For further information please contact:

Hydrodec Group plc

020 3300 1643

Chris Ellis, Chief Executive

Mike Preen, Company Secretary

Canaccord Genuity (Nominated Adviser and Broker)

020 7418 8900

Guy Marks

Henry Fitgerald-O'Connor

Vigo Communications (PR adviser to Hydrodec)

020 7016 9570

Patrick d'Ancona

Chris McMahon

Notes to Editors:

Hydrodec's technology is a proven, highly efficient, oil re-refining and chemical process initially targeted at the multi-billion US$ market for transformer oil used by the world's electricity industry. MarketsandMarkets forecasts that the global transformer oil market is expected to grow from US$1.98 billion in 2015 to US$2.79 billion by 2020 at a CAGR of 7.14% from 2015 to 2020. Spent oil is currently processed at two commercial plants with distinct competitive advantage delivered through very high recoveries (near 100%), producing 'as new' high quality oils at competitive cost and without environmentally harmful emissions. The process also completely eliminates PCBs, a toxic additive banned under international regulations. Hydrodec's plants are located at Canton, Ohio, US and Bomen, New South Wales, Australia.聽

Hydrodec's shares are listed on the AIM Market of the London Stock Exchange. For further information, please visit www.hydrodec.com.

This information is provided by RNS
The company news service from the London Stock Exchange
END
TSTAKCDNDBKBPOD
Date   Source Headline
8th Oct 20189:00 amRNSPrice Monitoring Extension
8th Oct 20187:00 amRNSProposed placing to raise a minimum of £10m
28th Sep 20183:45 pmRNSBusiness Review Update
10th Sep 20187:00 amRNSHalf-year Report
22nd Aug 20187:00 amRNSRe-refining technology patent extended to Europe
15th Aug 20183:27 pmRNSHolding(s) in Company
3rd Aug 20187:00 amRNSTrading Update
27th Jun 201812:10 pmRNSResult of AGM
4th Jun 20182:32 pmRNS2017 Annual Report and Accounts and Notice of AGM
31st May 20181:39 pmRNSDirector/PDMR Shareholding
31st May 201812:05 pmRNSFinal Results
25th May 20187:00 amRNSChange of Adviser
2nd May 20187:00 amRNSQ1 Trading Update
4th Apr 20187:00 amRNSDirectorate Change
29th Jan 20187:00 amRNSPre-close Trading Update
28th Dec 20177:00 amRNSExtension of working capital facilities
16th Nov 20172:00 pmRNSDirector/PDMR Shareholding
2nd Nov 20175:16 pmRNSHolding(s) in Company
31st Oct 201711:38 amRNSHolding(s) in Company
27th Oct 20177:00 amRNSGrant of options
26th Oct 20177:00 amRNSQ3 Trading Update
5th Oct 20177:00 amRNSHolding(s) in Company
25th Sep 20177:00 amRNSHalf Yearly Report
18th Sep 20177:00 amRNSNew patent
12th Jul 20177:00 amRNSCarbon Credit Service Agreement
27th Jun 201711:00 amRNSResult of AGM
27th Jun 20177:00 amRNSAGM Statement
2nd Jun 20179:32 amRNS2016 Annual Report and Accounts and Notice of AGM
12th May 20177:00 amRNSFinal Results
8th May 20177:00 amRNSInitial Sale of Carbon Credits
12th Apr 20177:00 amRNSQ1 2017 Trading Update
11th Apr 20174:11 pmRNSHolding(s) in Company
14th Feb 201710:52 amRNSHolding(s) in Company
14th Feb 201710:48 amRNSHolding(s) in Company
30th Jan 20177:00 amRNSPre-close Trading Update
24th Jan 201711:45 amRNSHolding(s) in Company
12th Dec 20167:00 amRNSTrading Update
20th Oct 201611:30 amRNSHolding(s) in Company
17th Oct 20167:00 amRNSAdditional Investment in Hydrodec of North America
11th Oct 201611:20 amRNSHolding(s) in Company
3rd Oct 20161:30 pmRNSChange of Registered Office
16th Sep 20167:00 amRNSHalf Yearly Report
8th Sep 20167:00 amRNSCarbon Credit Project Approval
18th Aug 20167:00 amRNSContract Win
21st Jul 20165:00 pmRNSHolding(s) in Company
20th Jul 20167:00 amRNSTrading Update
24th Jun 20164:58 pmRNSDirector/PDMR Shareholding
14th Jun 201612:50 pmRNSHolding(s) in Company
10th Jun 201612:53 pmRNSDirector's shareholding
9th Jun 20165:35 pmRNSDirectors' shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.